Moderna said on Thursday its COVID-19 shot was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial. That compares favorably to data from Pfizer Inc and BioNTech SE last week in which they said their vaccine's efficacy waned around 6% every two months, declining to around 84% six months after the second shot